NFKB1 and inflammatory bowel disease: Macrophage-specific NF-kB dynamics can isolate patients with IBD [43], and inhibitors, such as ASA and sulfasalazine, in models of DSS-induced colitis have been shown to reduce NF-kB activity and macrophage penetration [44].